ABBV vs COR
By Alex · Tickerpine
AbbVie Inc. vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | COR |
|---|---|---|
| Price | $253.35 | $286.13 |
| Market cap | $447.62B | $55.67B |
| P/E ratio | 123.6 | 21.9 |
| ROE | — | 107.13% |
| Profit margin | 5.79% | 0.78% |
| Revenue growth | 12.40% | 3.80% |
| Dividend yield | 2.73% | 0.84% |
| Beta | 0.31 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs COR in plain English
- ABBV is the bigger company — about 8.0× the market cap of COR.
- COR is cheaper on earnings (P/E 21.9 vs 123.6).
- ABBV is growing revenue faster (12% vs 4%).
- ABBV has the higher dividend yield (2.73% vs 0.84%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.